CHIP at a VAF of 10% or greater is the strongest predictor of whether daily low-dose aspirin can help prevent cancer in healthy, older adults.
Low-dose aspirin use is associated with a reduced risk for colorectal cancer (CRC), confirms a large-scale cohort study, which also suggests that the risk reduction is greatest for metastatic disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback